105 related articles for article (PubMed ID: 2221797)
21. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.
Pelikan DM; Lion HL; Hermans J; Goslings BM
Clin Endocrinol (Oxf); 1997 Dec; 47(6):713-20. PubMed ID: 9497879
[TBL] [Abstract][Full Text] [Related]
22. Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions.
Misaki T; Iwata M; Kasagi K; Konishi J
Ann Nucl Med; 2000 Apr; 14(2):111-4. PubMed ID: 10830528
[TBL] [Abstract][Full Text] [Related]
23. Occult distant metastases of well-differentiated thyroid carcinoma.
Zohar Y; Strauss M
Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741
[TBL] [Abstract][Full Text] [Related]
24. [Management and prognostic factors for 119 patients with follicular thyroid carcinoma].
Liu WS; Zhang GF; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):778-82. PubMed ID: 24378102
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.
Benbassat CA; Mechlis-Frish S; Hirsch D
World J Surg; 2006 Jun; 30(6):1088-95. PubMed ID: 16736341
[TBL] [Abstract][Full Text] [Related]
26. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
27. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
28. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
29. Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study.
Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Terahata S; Noguchi M; Hisada K; Matsubara F
Hum Pathol; 1990 Mar; 21(3):283-90. PubMed ID: 2312106
[TBL] [Abstract][Full Text] [Related]
30. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
32. Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases.
Harness JK; Thompson NW; Sisson JC; Beierwaltes WH
Arch Surg; 1974 Apr; 108(4):410-9. PubMed ID: 4815916
[No Abstract] [Full Text] [Related]
33. Radioiodine I-131 therapy in the management of differentiated thyroid carcinoma: a review of 202 patients.
Chen WL; Guan SI; Huang WS
J Formos Med Assoc; 1993 Jul; 92(7):623-31. PubMed ID: 7904498
[TBL] [Abstract][Full Text] [Related]
34. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
[TBL] [Abstract][Full Text] [Related]
35. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma.
Marcocci C; Pacini F; Elisei R; Schipani E; Ceccarelli C; Miccoli P; Arganini M; Pinchera A
Surgery; 1989 Dec; 106(6):960-6. PubMed ID: 2588123
[TBL] [Abstract][Full Text] [Related]
37. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
38. Efficacy analysis of (131)I therapy and predictive value of preablation stimulated thyroglobulin for lung metastases from differentiated thyroid cancer.
Wu S; Wang H
Ann Endocrinol (Paris); 2013 Feb; 74(1):40-4. PubMed ID: 23337017
[TBL] [Abstract][Full Text] [Related]
39. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.
Sohn SY; Kim HI; Kim YN; Kim TH; Kim SW; Chung JH
Clin Endocrinol (Oxf); 2018 Feb; 88(2):318-326. PubMed ID: 28972676
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]